IG
TXG icon

ING Group’s 10x Genomics TXG Stock Holding History

ING Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-286,500
Closed -$3.32M – 575
2025
Q2 		$3.32M Buy
286,500
+94,700
+49% +$863K 0.02% 298
2025
Q1 		$1.67M Buy
191,800
+116,400
+154% +$1.47M 0.01% 353
2024
Q4 		$1.08M Buy
+75,400
New +$1.19M 0.01% 494
2024
Q2 		– Sell
-46,400
Closed -$1.74M – 627
2024
Q1 		$1.74M Buy
+46,400
New +$2.04M 0.01% 462

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ING Group's TXG Position: Q3 2025 in Review

ING Group sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 286,500 shares — an estimated $3.32M sold.

ING Group first reported a position in TXG in Q1 2024 and held it in 4 quarters. The position peaked at $3.32M in Q2 2025. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • ING Group reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • ING Group sold 286,500 10x Genomics shares in Q3 2025, an estimated $3.32M.
  • ING Group first reported a position in 10x Genomics in Q1 2024 and held it in 4 quarters.
  • ING Group's 10x Genomics position peaked at $3.32M in Q2 2025.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on ING Group's 13F filing for Q3 2025, filed 6 Nov 2025.